We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.3B
AUM Growth
-$783M
Cap. Flow
-$715M
Cap. Flow %
-2.15%
Top 10 Hldgs %
15.9%
Holding
3,039
New
28
Increased
1,056
Reduced
1,268
Closed
57

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$29M
2
DISCK
Discovery, Inc. Series C Common Stock
DISCK
+$14M
3
MSFT icon
Microsoft
MSFT
+$10.8M
4
META icon
Meta Platforms (Facebook)
META
+$10.5M
5
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$6.72M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$34.4M
2
FRX
FOREST LABORATORIES INC
FRX
+$32.2M
3
XOM icon
ExxonMobil
XOM
+$23.9M
4
WBD icon
Warner Bros
WBD
+$15.4M
5
RTX icon
RTX Corp
RTX
+$13.7M

Sector Composition

Rank Sector Weight
1 Technology 14.81%
2 Financials 14.8%
3 Healthcare 13.73%
4 Industrials 10.72%
5 Energy 8.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LMIA
2776
DELISTED
LMI Aerospace Inc
LMIA
$192K ﹤0.01%
15,029
– –
FNLC icon
2777
First Bancorp
FNLC
$406M
$191K ﹤0.01%
11,476
– –
JIVE
2778
DELISTED
Jive Software, Inc.
JIVE
$191K ﹤0.01%
32,794
– –
SGM
2779
DELISTED
Stonegate Mortgage Corporation
SGM
$191K ﹤0.01%
14,695
+100
+0.7% +$1.39K
UNIS
2780
DELISTED
Unilife Corporation
UNIS
$191K ﹤0.01%
8,339
+500
+6% +$12.6K
SPNS
2781
DELISTED
Sapiens International
SPNS
$190K ﹤0.01%
25,740
+200
+0.8% +$1.56K
SUPN icon
2782
Supernus Pharmaceuticals
SUPN
$2.55B
$190K ﹤0.01%
21,842
– –
JAKK icon
2783
Jakks Pacific
JAKK
$296M
$188K ﹤0.01%
2,652
-107
-4% -$7.55K
LCUT icon
2784
Lifetime Brands
LCUT
$195M
$188K ﹤0.01%
12,289
– –
FFNW
2785
DELISTED
First Financial Northwest, Inc
FFNW
$188K ﹤0.01%
18,455
– –
RPRX
2786
DELISTED
Repros Therapeutics Inc.
RPRX
$188K ﹤0.01%
19,040
-480
-2% -$7.11K
CCO icon
2787
Clear Channel Outdoor Holdings
CCO
$1.23B
$187K ﹤0.01%
27,789
-593
-2% -$4.35K
PFSI icon
2788
PennyMac Financial
PFSI
$4.04B
$187K ﹤0.01%
12,739
– –
BBBY
2789
Bed Bath & Beyond
BBBY
$541M
$186K ﹤0.01%
14,657
– –
PETX
2790
DELISTED
Aratana Therapeutics, Inc.
PETX
$186K ﹤0.01%
18,515
– –
QNST icon
2791
QuinStreet
QNST
$892M
$185K ﹤0.01%
44,590
– –
ECYT
2792
DELISTED
Endocyte, Inc. Common Stock
ECYT
$183K ﹤0.01%
30,025
-1,200
-4% -$8.2K
ESBF
2793
DELISTED
E S B FINL CORP
ESBF
$183K ﹤0.01%
15,702
– –
AAOI icon
2794
Applied Optoelectronics
AAOI
$10.8B
$180K ﹤0.01%
11,210
-50
-0.4% -$991
ACIC icon
2795
American Coastal Insurance
ACIC
$533M
$180K ﹤0.01%
12,000
– –
HEOP
2796
DELISTED
Heritage Oaks Bancorp
HEOP
$179K ﹤0.01%
25,535
– –
BVH
2797
DELISTED
Bluegreen Vacations Holding Corporation
BVH
$178K ﹤0.01%
2,048
– –
HNR
2798
DELISTED
Harvest Natural Resources
HNR
$176K ﹤0.01%
11,965
– –
SKUL
2799
DELISTED
SKULLCANDY INC
SKUL
$176K ﹤0.01%
22,579
+2,200
+11% +$16.9K
MT icon
2800
ArcelorMittal
MT
$56.6B
$174K ﹤0.01%
5,572
– –
110 111
112
113 114

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q3 2014 Portfolio in Review

As of Q3 2014, RhumbLine Advisers held 3,039 positions worth $33.3B, down 2.3% from $34.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q3 2014: portfolio turnover was 2.8%. RhumbLine Advisers opened 28 new positions and exited 57, leaving the 3,039-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 346,925 shares worth $12.9M.
  • RhumbLine Advisers added most to Allergan plc in Q3 2014, an estimated $29M increase.
  • RhumbLine Advisers's biggest Q3 2014 reduction was Apple, cutting an estimated $34.4M.
  • RhumbLine Advisers fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $32.2M.
  • RhumbLine Advisers's ten largest holdings make up 16% of its $33.3B portfolio in Q3 2014.
  • RhumbLine Advisers opened 28 new positions and closed 57 in Q3 2014.
  • RhumbLine Advisers's portfolio value fell 2.3% quarter-over-quarter to $33.3B.

Based on RhumbLine Advisers's 13F filing for Q3 2014, filed 12 Nov 2014.